Team
Portfolio
News
Contact

Back to Portfolio

Mission Therapeutics

Website LinkedIn Twitter

Targeting the ubiquitin pathway with a new class of drugs

Therapeutic Area
CNS: Stage
Clinical: CEO
Anker Lundemose, MD, PhD: Board Member
Matthew Foy: Geography
Cambridge, UK

© 2024 SR One Capital ManagementLinkedIn

For media enquires, please email sronemedia@sambrown.com

California

929 Main Street
Suite 200
Redwood City, CA 94063
United States

Pennsylvania

985 Old Eagle School Road
Suite 511
Wayne, PA 19087
United States

London

29 Farm Street
London
W1J 5RL
United Kingdom

Privacy Policy California Privacy Policy EU Privacy Policy Terms & Conditions Regulatory Disclosures